ReviewMedicine2025
A case report of liver failure caused by Tetrastigma hemsleyanum Diels et Gilg: A rare case report and literature review.
Review in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
rationaleTetrastigma hemsleyanum Diels et Gilg is a traditional Chinese medicinal plant recognized for its therapeutic properties, which include heat-clearing, toxicity-eliminating, anti-inflammatory, pain-relieving, blood circulation-promoting, blood stasis-resolving, wind-dispersing, and phlegm-resolving actions. It is predominantly used in clinical settings to manage inflammatory disorders, such as febrile convulsions, hepatitis, snakebites, and cellulitis. To date, no documented cases of liver failure attributable to T hemsleyanum Diels et Gilg have been reported. PATIENT CONCERNS: A 50-year-old female patient presented with symptoms of xanthochromia, tea-colored urine, fatigue, and anorexia following a three-day course of T hemsleyanum Diels et Gilg. Liver function tests revealed elevated alanine aminotransferase (1386 U/L) and AST (405 U/L) levels. DIAGNOSES: Liver failure induced by T hemsleyanum Diels et Gilg was diagnosed.
interventionsThe patient received treatment that included discontinuation of hepatotoxic drugs, administration of N-acetylcysteine for liver protection, nutritional support, and correction of acid-base and electrolyte imbalances. OUTCOMES: After 11 days of liver-protective and nutritional therapy, significant improvements in the patient's condition were noted. The symptoms of xanthochromia and tea-colored urine subsided, and liver function markers decreased markedly, returning to near-normal levels. No further complaints of discomfort were reported, and the patient was discharged with prescribed medications for follow-up. LESSON: The possibility of liver failure following the use of T hemsleyanum Diels et Gilg should be considered. When patients present with symptoms such as fat intolerance, xanthochromia, poor appetite, nausea, and dark urine after consuming this herb, liver function tests should be promptly conducted to exclude the possibility of drug-induced liver injury. T hemsleyanum Diels et Gilg has the potential to induce liver failure. Liver-protective measures, including nutritional support, proved to be effective in managing the condition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.